Canada Gazette, Part I, Volume 155, Number 19: GOVERNMENT NOTICES
May 8, 2021
DEPARTMENT OF THE ENVIRONMENT
DEPARTMENT OF HEALTH
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Publication after screening assessment of 16 substances of the Monocyclic and Bicyclic Sesquiterpenes Group specified on the Domestic Substances List (paragraphs 68(b) and (c) or subsection 77(1) of the Canadian Environmental Protection Act, 1999)
Whereas 13 substances identified in the annex below are substances identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;
Whereas a summary of the draft screening assessment conducted on balsams copaiba, ginger oil, and sandalwood oil pursuant to paragraphs 68(b) and (c) of the Act and on 13 substances pursuant to section 74 of the Act is annexed hereby;
Whereas it is proposed to conclude that T & T clove oil, sandalwood oil, and guaiazulene meet one or more of the criteria set out in section 64 of the Act;
And whereas the Minister of the Environment and the Minister of Health (the ministers) are satisfied that the criteria set out under subsection 77(4) of the Act are met for T & T clove oil and guaiazulene,
Notice therefore is hereby given that the ministers propose to recommend to the Administrator in Council that T & T clove oil, sandalwood oil, and guaiazulene be added to Schedule 1 to the Act.
And whereas it is proposed to conclude that the remaining 13 substances do not meet any of the criteria set out in section 64 of the Act,
Notice therefore is hereby given that the ministers propose to take no further action at this time under section 77 of the Act for 11 substances identified under subsection 73(1) of the Act.
Notice is further given that the ministers propose to take no further action on the remaining two substances, balsams copaiba and ginger oil, at this time.
Notice is furthermore given that the ministers have released a risk management scope document for T & T clove oil, sandalwood oil, and guaiazulene to initiate discussions with stakeholders on the development of risk management options.
Public comment period
Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical Substances) website. All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be addressed to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by email to eccc.substances.eccc@canada.ca or by using the online reporting system available through Environment and Climate Change Canada's Single Window.
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.
Kwasi Nyarko
Acting Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment
Aimee Zweig
Acting Director General
Industrial Sectors and Chemicals Directorate
On behalf of the Minister of the Environment
David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health
ANNEX
Summary of the draft screening assessment of the Monocyclic and Bicyclic Sesquiterpenes Group
Pursuant to section 68 or 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of 16 of 76 substances referred to collectively under the Chemicals Management Plan as the Terpenes and Terpenoids Group. These 16 substances were identified as priorities for assessment as they met categorization criteria under subsection 73(1) of CEPA or were considered a priority on the basis of other human health concerns. The 16 substances addressed in this draft screening assessment report will hereafter be referred to as the Monocyclic and Bicyclic Sesquiterpenes Group. It consists of 14 substances that have been divided into 3 subgroups based on chemical structure, properties, and/or toxicity, as well as 2 individual substances, namely sandalwood oil and guaiazulene. The Chemical Abstracts Service Registry Numbers (CAS RNs footnote 1), the subgroup, the Domestic Substances List (DSL) names and the common name used in this assessment of these substances are listed in the table below.
| CAS RN | Subgroup | DSL name | Common name used in this assessment |
|---|---|---|---|
| 495-62-5 | 1 | Cyclohexene, 4-(1,5-dimethyl-4-hexenylidene)-1-methyl- | Bisabolene |
| 8001-61-4 table 1 note a , table 1 note b | 1 | Balsams, copaiba | Copaiba balsam |
| 8007-08-7 table 1 note a, table 1 note b | 1 | Oils, ginger | Ginger oil |
| 17627-44-0 | 1 | Cyclohexene, 4-(1,5-dimethyl-1,4-hexadienyl)-1-methyl- | alpha-Bisabolene |
| 65113-99-7 | 1 | 3-Cyclopentene-1-butanol, α,β,2,2,3-pentamethyl- | Sandalore |
| 107898-54-4 | 1 | 4-Penten-2-ol, 3,3-dimethyl-5-(2,2,3-trimethyl-3cyclopenten-1-yl)- | Santol pentenol |
| 87-44-5 | 2 | Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene, [1R-(1R,4E,9S)]- | beta-Caryophyllene |
| 88-84-6 | 2 | Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethylidene)-, (1S-cis)- | Guaiene |
| 3691-12-1 | 2 | Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, [1S-(1α,4α,7α)]- | alpha-Guaiene |
| 4630-07-3 | 2 | Naphthalene, 1,2,3,5,6,7,8,8a-octahydro-1,8a-dimethyl-7-(1-methylethenyl)-, [1R-(1α,7β,8aα)]- | Valencene |
| 68917-29-3 table 1 note b | 2 | Terpenes and terpenoids, clove oil | T & T clove oil |
| 489-86-1 | 3 | 5-Azulenemethanol, 1,2,3,4,5,6,7,8-octahydroα,α,3,8-tetramethyl-,[3S-(3α,5α,8α)]- | Guaiol |
| 639-99-6 | 3 | Cyclohexanemethanol, 4-ethenyl-α,α,4-trimethyl-3-(1-methylethenyl)-, [1R-(1α,3α,4β)]- | Elemol |
| 22451-73-6 | 3 | 5-Azulenemethanol, 1,2,3,3a,4,5,6,7-octahydro-α,α,3,8-tetramethyl-, [3S-(3α,3aβ,5α)]- | Bulnesol |
| 489-84-9 | Individual | Azulene, 1,4-dimethyl-7-(1-methylethyl)- | Guaiazulene |
| 8006-87-9 table 1 note a , table 1 note b | Individual | Oils, sandalwood | Sandalwood oil |
Table 1 note(s)
|
|||
Terpenes are composed of repeating isoprene units and are classified according to the number of isoprene units they contain. Monoterpenes are the smallest and contain two isoprene units. Sesquiterpenes are larger and contain three isoprene units. Like monoterpenes, sesquiterpenes may be acyclic or cyclic, including many unique combinations. These substances are components of essential oils found in a wide variety of plants.
Most of the substances in the Monocyclic and Bicyclic Sesquiterpenes Group, except for alpha-guaiene, have been included in a survey issued pursuant to section 71 of CEPA, where none of the substances were reported to be manufactured above the reporting threshold of 100 kg. Santol pentenol, sandalore, and beta-caryophyllene were reported to be imported into Canada in quantities of up to 10 000 kg, while no imports of the other substances were reported. They are generally used as fragrances in self-care products (e.g. body lotion, massage products, hair care products, oral care products, drugs, non-prescription and natural health products), cleaning products, and air fresheners. They are also present in pest control products as formulants. In addition, some of them occur naturally in food and/or may be used as food flavouring agents.
The ecological risks of substances in the Monocyclic and Bicyclic Sesquiterpenes Group were characterized using the ecological risk classification of organic substances (ERC) approach, which is a risk-based approach that employs multiple metrics for both hazard and exposure, with weighted consideration of multiple lines of evidence for determining risk classification (ECCC 2016a). Hazard profiles are based principally on metrics regarding mode of toxic action, chemical reactivity, food web-derived internal toxicity thresholds, bioavailability, and chemical and biological activity. Metrics considered in the exposure profiles include potential emission rate, overall persistence, and long-range transport potential. A risk matrix is used to assign a low, moderate or high level of potential concern for substances on the basis of their hazard and exposure profiles. Based on the outcome of the ERC analysis, the 16 substances in the Monocyclic and Bicyclic Sesquiterpenes Group are considered unlikely to be causing ecological harm.
Considering all available lines of evidence presented in this draft screening assessment, there is a low risk to the environment from substances in the Monocyclic and Bicyclic Sesquiterpenes Group. It is proposed to conclude that the 16 substances in the Monocyclic and Bicyclic Sesquiterpenes Group do not meet the criteria under paragraph 64(a) or (b) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.
For the human health risk assessment, 14 of the substances in this group have been addressed under three subgroups, due to similarities in chemical structure, properties and/or toxicity, while the remaining two substances were addressed individually. An impact on human health from exposure to these substances from environmental media is not expected. Where applicable, exposures were characterized from use of self-care products, possible use as food flavouring agents, cleaning products, and air fresheners containing the monocyclic and bicyclic sesquiterpenes and are expected to be predominantly via the dermal and inhalation routes.
For subgroup 1, ginger oil, bisabolene, alpha-bisabolene, santol pentenol, sandalore, and copaiba balsam demonstrated a low hazard potential. Therefore, the risk to human health was also considered to be low.
For subgroup 2 (beta-caryophyllene, T & T clove oil, guaiene, alpha-guaiene and valencene), hazard information for beta-caryophyllene was used to inform the hazard assessment. Beta-caryophyllene is the main component in T & T clove oil. It was also identified as a read-across analogue for guaiene, alpha-guaiene, and valencene. For beta-caryophyllene, critical health effects were in the lymphoid system, liver, and mesenteric lymph nodes. A comparison of estimated levels of exposure to guaiene and valencene from food, to beta-caryophyllene from food, cleaning products, air fresheners, and cold sore cream, to T & T clove oil from body lotion, massage oil, and mouthwash, and to alpha-guaiene from its potential use as a fragrance ingredient with critical effect levels results in margins that are considered adequate to address uncertainties in the health effects and exposure data. A comparison of estimated levels of exposure to T & T clove oil from its use as a body fragrance with critical effect levels results in margins that are considered potentially inadequate to address uncertainties in the health effects and exposure data.
For subgroup 3 (guaiol, bulnesol, elemol), read-across data from the analogue alpha-terpineol was used to inform the hazard assessment. Critical health effects were observed on the male reproductive system. A comparison of estimated levels of exposure to bulnesol and elemol from food with critical effect levels results in margins that are considered adequate to address uncertainties in the health effects and exposure data. In addition, calculated margins of exposure to elemol from its potential use as a fragrance ingredient are considered adequate to address uncertainties in the health effects and exposure data. Since there were no identified sources of exposure for the general population to guaiol, a qualitative approach to risk characterization was taken, and the risk to human health from guaiol was considered to be low.
For sandalwood oil, read-across data from the analogue, bisabolol was used to inform the hazard assessment. Critical health effects from the dermal route of exposure were a decrease in body weight gain, decrease in feed efficiency, decrease of absolute liver weight and increase in relative testes weight. Critical health effects from the oral route of exposure were sedation, ataxia, reduced feed intake, and reduction of body weight gain in females and a significant reduction in fetal number and increase in resorption rate. A comparison of estimated levels of exposure to sandalwood oil from food, massage oil (in individuals nine years of age and older), facial moisturizer, shampoo, acne medication (i.e. facial cleansing system), sunscreen, cleaning products, laundry detergent, and use in aromatherapy with critical effect levels results in margins that are considered adequate to address uncertainties in the health effects and exposure data. A comparison of estimated levels of exposure to sandalwood oil from body lotion, massage oil (in infants and children up to eight years of age), and use of the essential oil as a body fragrance with critical effect levels results in margins that are considered potentially inadequate to address uncertainties in the health effects and exposure data.
For guaiazulene, naphthalene was used as a read-across analogue to inform the hazard assessment. Critical health effects from the dermal route of exposure were effects on the testes and non-neoplastic lesions in the cervical lymph nodes, liver, thyroid, kidneys, urinary bladder, and skin. From the inhalation route of exposure, critical health effects were atrophy/disorganization of the olfactory epithelium and hyperplasia of the respiratory and transitional epithelium. A comparison of estimated levels of exposure to guaiazulene from body lotion, facial moisturizer, conditioner, and aftershave product with critical effect levels results in margins that are considered adequate to address uncertainties in the health effects and exposure data. A comparison of estimated levels of exposure by the dermal or inhalation route to guaiazulene from a hair perm or straightening product with critical effect levels results in margins that are considered potentially inadequate to address uncertainties in the health effects and exposure data.
A summary of the potential health effects of concern, the products of concern, and the age groups impacted for T & T clove oil, sandalwood oil, and guaiazulene is listed in the statements that follow.
T & T clove oil may cause effects on the liver and lymphatic system when used in certain products and for certain age groups:
- Essential oil when used as a body fragrance/perfume: children aged 2 to 8
Sandalwood oil may cause developmental effects and effects on body weight, the liver and testes when used in certain products and for certain age groups:
- Body lotion: all ages
- Essential oil when used as a body fragrance: all ages beginning at the 2 to 8 age group
- Massage oil: infants and children up to 8 years old
Guaiazulene may cause effects on the testes, non-cancerous tumours and effects on the respiratory system when used in certain products and for certain age groups:
- Hair perm/straightening product: all ages beginning at the 4 to 8 age group
Considering all the information presented in this draft screening assessment, it is proposed to conclude that bisabolene, copaiba balsam, ginger oil, alpha-bisabolene, sandalore, santol pentenol, beta-caryophyllene, guaiene, alpha-guaiene, valencene, guaiol, elemol, and bulnesol do not meet the criteria under paragraph 64(c) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.
Considering all the information presented in this draft screening assessment, it is proposed to conclude that T & T clove oil, sandalwood oil and guaiazulene meet the criteria under paragraph 64(c) of CEPA, as they are entering or may enter the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.
Proposed overall conclusion
Therefore, it is proposed to conclude that T & T clove oil, sandalwood oil and guaiazulene meet one or more of the criteria set out in section 64 of CEPA and that the remaining 13 substances in the Monocyclic and Bicyclic Sesquiterpenes Group do not meet any of the criteria set out in section 64 of CEPA.
It is also proposed to conclude that T & T clove oil and guaiazulene meet the persistence and bioaccumulation criteria and that sandalwood oil does not meet the persistence or bioaccumulation criteria as set out in the Persistence and Bioaccumulation Regulations of CEPA.
The draft screening assessment and the risk management scope document for these substances are available on the Canada.ca (Chemical Substances) website.
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Saanich Police Department as fingerprint examiners:
- Mark Kubitza
- Brad Walsh
Ottawa, March 19, 2021
Talal Dakalbab
Assistant Deputy Minister
Community Safety and Countering Crime Branch
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the Toronto Police Service as a fingerprint examiner:
- Cheri Perdicaris
Ottawa, March 19, 2021
Talal Dakalbab
Assistant Deputy Minister
Community Safety and Countering Crime Branch
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as counterfeit examiner
Pursuant to subsection 461(2) of the Criminal Code, I hereby revoke the designation of the following person of the Royal Canadian Mounted Police as a counterfeit examiner:
- Marie Frances Porelle
Ottawa, March 19, 2021
Talal Dakalbab
Assistant Deputy Minister
Community Safety and Countering Crime Branch
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following person of the Toronto Police Service as a fingerprint examiner:
- Christianne Lys
Ottawa, March 19, 2021
Talal Dakalbab
Assistant Deputy Minister
Community Safety and Countering Crime Branch
DEPARTMENT OF TRANSPORT
CANADA MARINE ACT
Trois-Rivières Port Authority — Supplementary letters patent
WHEREAS letters patent were issued by the Minister of Transport (“Minister”) for the Trois-Rivières Port Authority (“Authority”), under the authority of the Canada Marine Act (“Act”), effective May 1, 1999;
WHEREAS Schedule C of the letters patent sets out the immovables, other than federal immovables, held or occupied by the Authority;
WHEREAS, pursuant to subsection 46(2.1) of the Act, the Authority wishes to acquire the immovables known and designated as being lots 1 019 100 and 3 477 703 of the cadastre of Quebec;
WHEREAS the board of directors of the Authority has requested that the Minister issue supplementary letters patent to set out the said immovables in Schedule C of the letters patent;
AND WHEREAS the Minister is satisfied that the amendment to the letters patent is consistent with the Act;
NOW THEREFORE, pursuant to subsection 9(1) of the Act, the letters patent are amended as follows:
| Lot Number | Description |
|---|---|
| 1 019 100 | An immovable known and designated in the Land register of Québec as being lot 1 019 100, containing an area of 486.8 m2. |
| 3 477 703 | An immovable known and designated in the Land register of Québec as being part of lot 3 477 703, containing an area of 646.0 m2. |
2. These supplementary letters patent take effect on the date of registration in the Land register of Québec of the deed of sale evidencing the transfer of the immovables to the Authority.
ISSUED this 8th day of April, 2021.
The Honourable Omar Alghabra, P.C., M.P.
Minister of Transport
DEPARTMENT OF TRANSPORT
CANADA MARINE ACT
Trois-Rivières Port Authority — Supplementary letters patent
WHEREAS letters patent were issued by the Minister of Transport (“Minister”) for the Trois-Rivières Port Authority (“Authority”), under the authority of the Canada Marine Act (“Act”), effective May 1, 1999;
WHEREAS Schedule C of the letters patent sets out the immovables, other than federal immovables, held or occupied by the Authority;
WHEREAS, pursuant to subsection 46(2.1) of the Act, the Authority wishes to acquire the immovable known and designated as being lot 1 019 119 of the cadastre of Quebec;
WHEREAS the board of directors of the Authority has requested that the Minister issue supplementary letters patent to set out the said immovable in Schedule C of the letters patent;
AND WHEREAS the Minister is satisfied that the amendment to the letters patent is consistent with the Act;
NOW THEREFORE, pursuant to subsection 9(1) of the Act, the letters patent are amended as follows:
| Lot Number | Description |
|---|---|
| 1 019 119 | An immovable known and designated in the Land register of Québec as being lot 1 019 119, containing an area of 2 380.90 m2. |
2. These supplementary letters patent take effect on the date of registration in the Land register of Québec of the deed of sale evidencing the transfer of the immovable to the Authority.
ISSUED this 8th day of April, 2021.
The Honourable Omar Alghabra, P.C., M.P.
Minister of Transport
PRIVY COUNCIL OFFICE
Appointment opportunities
We know that our country is stronger — and our government more effective — when decision-makers reflect Canada's diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.
We are equally committed to providing a healthy workplace that supports one's dignity, self-esteem and the ability to work to one's full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.
The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.
Current opportunities
The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.
| Position | Organization | Closing date |
|---|---|---|
| Member | Atlantic Pilotage Authority Canada | |
| Commissioner | British Columbia Treaty Commission | |
| Director | Business Development Bank of Canada | |
| President and Chief Executive Officer | Business Development Bank of Canada | |
| Member | Canada Council for the Arts | |
| Vice-Chairperson | Canada Council for the Arts | |
| President and Chief Executive Officer | Canada Development Investment Corporation | |
| Commissioner for Employers | Canada Employment Insurance Commission | |
| Director | Canada Infrastructure Bank | |
| Director | Canada Mortgage and Housing Corporation | |
| Chairperson | Canada-Nova Scotia Offshore Petroleum Board | |
| Member of the Board of Directors | Canada Post | |
| Member | Canadian Cultural Property Export Review Board | |
| Chairperson | Canadian Dairy Commission | |
| Chief Executive Officer | Canadian Dairy Commission | |
| Director | Canadian Energy Regulator | |
| Federal Housing Advocate | Canadian Human Rights Commission | |
| Chairperson | Canadian Human Rights Tribunal | |
| Member | Canadian Human Rights Tribunal | |
| Member | Canadian Institutes of Health Research | |
| Chairperson | Canadian Museum of History | |
| Director | Canadian Museum of History | |
| Director | Canadian Race Relations Foundation | |
| Chairperson | Canadian Transportation Agency | |
| Temporary Member | Canadian Transportation Agency | |
| Chairperson | Destination Canada | |
| Director | Destination Canada | |
| Director | Farm Credit Canada | |
| Vice-Chairperson | Federal Public Sector Labour Relations and Employment Board | |
| Director | Freshwater Fish Marketing Corporation | |
| Member | Great Lakes Pilotage Authority Canada | |
| Director (Federal) |
Hamilton-Oshawa Port Authority | |
| Member, Yukon | Historic Sites and Monuments Board of Canada | |
| Governor | International Development Research Centre | |
| Member (appointment to roster) |
International Trade and International Investment Dispute Settlement Bodies | |
| Chairperson | Laurentian Pilotage Authority Canada | |
| Director | Marine Atlantic Inc. | |
| Chairperson | Military Police Complaints Commission of Canada | |
| Member | Military Police Complaints Commission of Canada | |
| Member | National Arts Centre Corporation | |
| Member | National Research Council Canada | |
| Member | National Seniors Council | |
| Commissioner and Director | Office of the Commissioner of Indigenous Languages | |
| Superintendent | Office of the Superintendent of Financial Institutions Canada | |
| Member | Payments in Lieu of Taxes Dispute Advisory Panel | |
| Director | Public Sector Pension Investment Board of Canada | |
| Commissioner | Roosevelt Campobello International Park Commission | |
| Chairperson | Standards Council of Canada | |
| Registrar | Supreme Court of Canada | |
| Director (Federal) |
Toronto Port Authority | |
| Chairperson and Member | Transportation Appeal Tribunal of Canada | |
| Vice-Chairperson | Transportation Appeal Tribunal of Canada | |
| Director (Federal) |
Trois-Rivières Port Authority |
BANK OF CANADA
Statement of financial position as at March 31, 2021 (unaudited)
Amounts are in millions of dollars.
Totals
| Item | Amount |
|---|---|
| Assets | 552,385.5 |
| Liabilities and Equity | 552,385.5 |
Assets
| Item | Amount |
|---|---|
| Cash and foreign deposits | 5.7 |
| Item | Amount |
|---|---|
| Securities purchased under resale agreements | 113,699.4 |
| Advances to members of Payments Canada | n/a |
| Other receivables | 6.5 |
| Total loans and receivables | 113,705.9 |
| Item | Amount |
|---|---|
| Government of Canada treasury bills | 41,341.3 |
| Government of Canada bonds — carried at amortized cost | 111,101.5 |
| Government of Canada bonds — carried at fair value through profit and loss | 227,977.0 |
| Canada Mortgage Bonds | 9,651.2 |
| Other bonds | 17,881.4 |
| Securities lent or sold under repurchase agreements | 19,617.0 |
| Other securities | 2,033.1 |
| Shares in the Bank for International Settlements (BIS) | 469.6 |
| Total investments | 430,072.1 |
| Item | Amount |
|---|---|
| Derivatives — Indemnity agreements with the Government of Canada | 7,763.2 |
| Item | Amount |
|---|---|
| Property and equipment | 558.5 |
| Intangible assets | 88.7 |
| Right-of-use leased assets | 44.2 |
| Total capital assets | 691.4 |
| Item | Amount |
|---|---|
| Other assets | 147.2 |
Liabilities and Equity
| Item | Amount |
|---|---|
| Bank notes in circulation | 105,618.9 |
| Item | Amount |
|---|---|
| Government of Canada | 57,532.0 |
| Members of Payments Canada | 359,610.9 |
| Other deposits | 9,010.4 |
| Total deposits | 426,153.3 |
| Item | Amount |
|---|---|
| Securities sold under repurchase agreements | 18,759.0 |
| Item | Amount |
|---|---|
| Derivatives — Indemnity agreements with the Government of Canada | n/a |
| Item | Amount |
|---|---|
| Other liabilities | 1,292.7 |
| Item | Amount |
|---|---|
| Total liabilities | 551,823.9 |
| Item | Amount |
|---|---|
| Share capital | 5.0 |
| Statutory and special reserves | 125.0 |
| Investment revaluation reserve | 431.6 |
| Total equity | 561.6 |
I declare that the foregoing statement is correct according to the books of the Bank.
Ottawa, April 28, 2021
Coralia Bulhoes
Chief Financial Officer and Chief Accountant
I declare that the foregoing statement is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.
Ottawa, April 28, 2021
Tiff Macklem
Governor